Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Verve Therapeutics, Inc. Common Stock | VERV

Daily Technical Analysis of Verve Therapeutics, Inc. Common Stock

Verve Therapeutics had a rough day and is now down -5.99%. Investors weren't too impressed with the future outlook for the asset which caused some selling on weak demand.

Currently VERV isn't at a clear support/resistance line that seems tradable. Momentum wise Verve Therapeutics, has been oscillating up and down but hasn't shown much directional energy that would be predictive to the near future. VERV might find some support at the 11.14 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2024-11-13

Analyst Ratings for Verve Therapeutics By Price Target And Rating

The analysts are pretty neutral on Verve Therapeutics right now, so not much useful information here. The current Analysts Sentiment Score is 6.74. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. Royal Bank of Canada announced that they are reiterating a rating of Outperform on 2024-02-28 and added a price target of $35.00. William Blair reiterated a rating of Outperform on 2023-11-13. Cantor Fitzgerald announced that they are reiterating a rating of Neutral on 2023-09-13 and they set their price target at $22.00. Guggenheim dropped their price target by -1.79% to $55.00 on 2023-08-15. Credit Suisse Group reiterated a rating of Neutral on 2023-08-11 and provided a price target of $31.00. On 2023-08-08 there was confirmation of the previous rating by Lifesci Capital which was Outperform. Canaccord Genuity Group initiated a rating of Buy on 2023-04-13 and provided a price target of $29.00.

Company Ratings Score ?
Composite analyst sentiment score
Positive Ratings Negative Ratings Boost Price Target Lower Price Target
VERV6.747.3406.6-0.45

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2024-03-29)
Company YOY Growth Score (typical -20 to +20) Revision Directions (-6 to +6)
VERV0.000.00

Short interest for Verve Therapeutics

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company Short Score (typical 1-15) ?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
Short Interest Days to Cover Rate of Change Shares Short
VERV20.4%26.716-6.86411420000

Social Sentiment for Verve Therapeutics

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker Social Sentiment(1-10)
VERV

Sentiment Score

How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.

Earnings Estimates
Analyst Rating
Price Targets
Short Interest
Financials
Options Sentiment
Institutional Ownership
Social Sentiment
Fidelity Summary
Overall Summary Notes
Calculated Sentiment Sum

Score Sum
(1-45)

/

Average
(1-5)

+

Pattern Rank
(1-5)

=

Total Score
(1-10)

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-